Recombinant Human IL2RA protein, His-Avi-tagged, Biotinylated
Cat.No. : | IL2RA-1633H |
Product Overview : | Biotinylated Recombinant Human IL2RA protein(P01589)(Glu22-Cys213), fused with C-terminal His and Avi tag, was expressed in HEK293. |
- Specification
- Gene Information
- Related Products
- Download
Source : | HEK293 |
Species : | Human |
Tag : | C-His-Avi |
Protein length : | Glu22-Cys213 |
Conjugation/Label : | Biotin |
Form : | Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). Normally 5% trehalose is added as protectant before lyophilization. |
Bio-activity : | Immobilized Anti-CD25 Antibody, hFc Tag at 0.2μg/ml (100μl/well) on the plate. Dose response curve for Biotinylated Human IL-2 R alpha, His Tag with the EC50 of 11.9ng/ml determined by ELISA. |
Molecular Mass : | The protein has a predicted MW of 24.6 kDa. Due to glycosylation, the protein migrates to 40-50 kDa based on Tris-Bis PAGE result. |
Endotoxin : | Less than 1EU per μg by the LAL method. |
Purity : | > 95% as determined by Tris-Bis PAGE; > 95% as determined by HPLC |
Storage : | Reconstituted protein stable at -80°C for 12 months, 4°C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
Reconstitution : | Centrifuge tubes before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water. |
Gene Name : | IL2RA interleukin 2 receptor, alpha [ Homo sapiens ] |
Official Symbol : | IL2RA |
Synonyms : | IL2RA; interleukin 2 receptor, alpha; IL2R; interleukin-2 receptor subunit alpha; CD25; p55; IL2-RA; IL-2-RA; TAC antigen; IL-2R subunit alpha; IL-2 receptor subunit alpha; TCGFR; IDDM10; |
Gene ID : | 3559 |
mRNA Refseq : | NM_000417 |
Protein Refseq : | NP_000408 |
MIM : | 147730 |
UniProt ID : | P01589 |
Products Types
◆ Recombinant Protein | ||
Il2ra-1676M | Recombinant Mouse Il2ra Protein, His-tagged | +Inquiry |
IL2RA-1715H | Recombinant Human IL2RA protein(22-185aa), His-GST-tagged | +Inquiry |
IL2RA-319H | Recombinant Human IL2RA Protein, His-tagged | +Inquiry |
IL2RA-186H | Recombinant Human IL2RA Protein (ECD), His-tagged(C-ter) | +Inquiry |
IL2RA-636H | Recombinant Human IL2RA protein(Met1-Cys213), hFc-tagged | +Inquiry |
◆ Lysates | ||
IL2RA-2024MCL | Recombinant Mouse IL2RA cell lysate | +Inquiry |
IL2RA-1015CCL | Recombinant Cynomolgus IL2RA cell lysate | +Inquiry |
Related Gene
Not For Human Consumption!
Inquiry
- Reviews
- Q&As
Customer Reviews (3)
Write a reviewSecurity is very high and can be used with confidence.
Structure is very stable and not prone to mutation.
The amount of expression is very high and can be easily detected.
Q&As (6)
Ask a questionThe combination of IL2RA and other drugs may produce nausea, vomiting, rash and other adverse reactions, should be monitored.
The frequency of use of IL2RA depends on the specific situation of the patient, and is generally used 1-3 times per week.
IL2RA, in the right dosage and frequency of use, can significantly relieve symptoms of diseases such as autoimmune diseases and organ transplant rejection.
Can assist in the treatment of some types of malignant tumors, but it is not a complete cure for cancer.
The effective rate of IL2RA therapy depends on many factors such as the type of disease, the patient's condition and the treatment regimen, and the effective rate is generally between 50% and 90%.
Indications of IL2RA include a variety of autoimmune diseases, organ transplant rejection and malignant tumors.
Ask a Question for All IL2RA Products
Required fields are marked with *
My Review for All IL2RA Products
Required fields are marked with *
Inquiry Basket